ITM Isotopen Technologien Muenchen AG, of Garching, Germany, said it raised €20 million (US$22 million) in equity from Medtech Focused Family Office. ITM plans to use the funds to further develop its pipeline of targeted radionuclide therapies for therapeutic and diagnostic purposes.